Basiliximab with delayed introduction of calcineurin inhibitors as a renal-sparing protocol following liver transplantation in children with renal impairment-Reference-Cited by-同舟云学术

Basiliximab with delayed introduction of calcineurin inhibitors as a renal-sparing protocol following liver transplantation in children with renal impairment

Published:2013-09-30 Issue:8 Volume:17 Page:751-756
ISSN:1397-3142
Container-title:Pediatric Transplantation
language:en
Short-container-title:Pediatr Transplantation

Author:

Mouzaki M.¹,Yap J.²,Avinashi V.¹,Babu A.¹,Fu A.¹,Deangelis M.¹,Van Roestel K.¹,Ghanekar A.¹³,Kamath B.¹,Avitzur Y.¹,Fecteau A.¹,Jones N.¹,Ling S.¹,Grant D.¹³,Ng V.¹

Affiliation:

1. SickKids Transplant Centre; The Hospital for Sick Children; University of Toronto; Toronto ON Canada

2. Stollery Children's Hospital; University of Alberta; Edmonton AB Canada

3. Toronto General Hospital; Toronto ON Canada

Publisher

Wiley

Subject

Transplantation,Pediatrics, Perinatology, and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/petr.12158/fullpdf

Reference20 articles.

1. Risk factors for end-stage kidney disease after pediatric liver transplantation;Ruebner;Am J Transplant,2012